{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:49:20Z","timestamp":1789364960787,"version":"build-2803163510"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:00:00Z","timestamp":1455840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0148366","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T13:49:42Z","timestamp":1455889782000},"page":"e0148366","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine"],"prefix":"10.1371","volume":"11","author":[{"given":"Saurabh","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Aresu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Comazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Worrall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hemmington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euan","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmare A.","family":"Limeneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ruckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borek","family":"Vojtesek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Fahraeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Argyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted R.","family":"Hupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,19]]},"reference":[{"key":"ref1","first-page":"481","article-title":"One world\u2014one medicine\u2014one health: emerging veterinary challenges and opportunities","volume":"28","author":"B Osburn","year":"2009","journal-title":"Revue scientifique et technique"},{"issue":"Suppl 2","key":"ref2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/tbed.12145","article-title":"The components of &apos;One World\u2014One Health&apos; approach","volume":"60","author":"P Calistri","year":"2013","journal-title":"Transboundary and emerging diseases"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/embor.2013.61","article-title":"One world, one health. Humans, animals and the environment are inextricably linked\u2014a fact that needs to be remembered and exploited in our modern approach to health","volume":"14","author":"PD van Helden","year":"2013","journal-title":"EMBO reports"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.vetpar.2013.04.004","article-title":"One world health: socioeconomic burden and parasitic disease control priorities","volume":"195","author":"PR Torgerson","year":"2013","journal-title":"Veterinary parasitology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: a population-based cost analysis","volume":"14","author":"R Luengo-Fernandez","year":"2013","journal-title":"The lancet oncology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.nbt.2012.03.003","article-title":"Analysing stratified medicine business models and value systems: innovation-regulation interactions","volume":"29","author":"J Mittra","year":"2012","journal-title":"New biotechnology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-4614-8244-4_16","article-title":"Magnetic resonance imaging of metastases in xenograft mouse models of cancer","volume":"1070","author":"K Peldschus","year":"2014","journal-title":"Methods in molecular biology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2013.10.010","article-title":"One mouse, one patient paradigm: New avatars of personalized cancer therapy","volume":"344","author":"P Malaney","year":"2014","journal-title":"Cancer letters"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/path.4285","article-title":"Mouse tumour models to guide drug development and identify resistance mechanisms","volume":"232","author":"M Das Thakur","year":"2014","journal-title":"The Journal of pathology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1158\/0008-5472.CAN-13-1069","article-title":"Patient-derived tumor xenografts: transforming clinical samples into mouse models","volume":"73","author":"D Siolas","year":"2013","journal-title":"Cancer research"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"I Kola","year":"2004","journal-title":"Nature reviews Drug discovery"},{"key":"ref12","first-page":"97","article-title":"Oncology of companion animals as a model for humans. an overview of tumor histotypes","volume":"25","author":"A Porrello","year":"2006","journal-title":"Journal of experimental & clinical cancer research: CR"},{"key":"ref13","first-page":"216","article-title":"Not lost in translation: how study of diseases in our pets can benefit them and us","volume":"110","author":"CJ Henry","year":"2013","journal-title":"Missouri medicine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tvjl.2010.10.018","article-title":"The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas","volume":"190","author":"R Klopfleisch","year":"2011","journal-title":"Veterinary journal"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.trsl.2011.11.005","article-title":"Canine tumors: a spontaneous animal model of human carcinogenesis","volume":"159","author":"SS Pinho","year":"2012","journal-title":"Translational research: the journal of laboratory and clinical medicine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-genet-102808-115200","article-title":"Man&apos;s best friend becomes biology&apos;s best in show: genome analyses in the domestic dog","volume":"44","author":"HG Parker","year":"2010","journal-title":"Annual review of genetics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1000310","DOI":"10.1371\/journal.pbio.1000310","article-title":"Canine morphology: hunting for genes and tracking mutations","volume":"8","author":"AL Shearin","year":"2010","journal-title":"PLoS biology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2013.03.005","article-title":"A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies","volume":"88","author":"G Ranieri","year":"2013","journal-title":"Critical reviews in oncology\/hematology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nbt0906-1065b","article-title":"The dog as a cancer model","volume":"24","author":"C Khanna","year":"2006","journal-title":"Nature biotechnology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nbt.2793","article-title":"Companion therapeutics","volume":"32","author":"G Sinha","year":"2014","journal-title":"Nature biotechnology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"AM Scott","year":"2012","journal-title":"Nature reviews Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri2744","article-title":"Monoclonal antibodies: versatile platforms for cancer immunotherapy","volume":"10","author":"LM Weiner","year":"2010","journal-title":"Nature reviews Immunology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.autrev.2005.04.004","article-title":"CD20: a target antigen for immunotherapy of autoimmune diseases","volume":"4","author":"F Perosa","year":"2005","journal-title":"Autoimmunity reviews"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.1021\/bi0511078","article-title":"Isolation and characterization of the B-cell marker CD20","volume":"44","author":"JA Ernst","year":"2005","journal-title":"Biochemistry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/14712598.2013.786698","article-title":"Rituximab in the treatment of non-Hodgkin&apos;s lymphoma\u2014a critical evaluation of randomized controlled trials","volume":"13","author":"MM Griffin","year":"2013","journal-title":"Expert opinion on biological therapy"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin&apos;s lymphoma","volume":"90","author":"DG Maloney","year":"1997","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1191\/0961203305lu2138oa","article-title":"Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases","volume":"14","author":"SA Chambers","year":"2005","journal-title":"Lupus"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrneph.2012.289","article-title":"Rituximab therapy in nephrotic syndrome: implications for patients&apos; management","volume":"9","author":"A Sinha","year":"2013","journal-title":"Nature reviews Nephrology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jaci.2010.02.025","article-title":"Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseases","volume":"125","author":"S Lee","year":"2010","journal-title":"The Journal of allergy and clinical immunology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e66308","DOI":"10.1371\/journal.pone.0066308","article-title":"Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review","volume":"8","author":"T Castillo-Trivino","year":"2013","journal-title":"PloS one"},{"key":"ref31","article-title":"Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients","author":"AA Vo","year":"2014","journal-title":"Transplantation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/14712598.2013.787064","article-title":"Rituximab biosimilars","volume":"13","author":"EM Vital","year":"2013","journal-title":"Expert opinion on biological therapy"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrclinonc.2011.160","article-title":"Clinical radioimmunotherapy\u2014the role of radiobiology","volume":"8","author":"JP Pouget","year":"2011","journal-title":"Nature reviews Clinical oncology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1586\/14737140.2.5.485","article-title":"Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma","volume":"2","author":"AJ Grillo-Lopez","year":"2002","journal-title":"Expert review of anticancer therapy"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1182\/blood.V99.12.4336","article-title":"Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial","volume":"99","author":"GA Wiseman","year":"2002","journal-title":"Blood"},{"key":"ref36","article-title":"Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications","author":"D Ito","year":"2014","journal-title":"Veterinary immunology and immunopathology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e72591","DOI":"10.1371\/journal.pone.0072591","article-title":"Comparative gene expression profiling identifies common molecular signatures of NF-kappaB activation in canine and human diffuse large B cell lymphoma (DLBCL)","volume":"8","author":"MA Mudaliar","year":"2013","journal-title":"PloS one"},{"key":"ref38","article-title":"Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential","author":"D Ito","year":"2014"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0022-1759(81)90286-6","article-title":"A rapid antibody assay system for screening hybridoma cultures","volume":"47","author":"DP Lane","year":"1981","journal-title":"Journal of immunological methods"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e92707","DOI":"10.1371\/journal.pone.0092707","article-title":"Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma","volume":"9","author":"S Ferraresso","year":"2014","journal-title":"PloS one"},{"key":"ref41","article-title":"Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma","author":"A Poggi","year":"2013","journal-title":"Veterinary and comparative oncology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tvjl.2010.03.011","article-title":"Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma","volume":"188","author":"S Comazzi","year":"2011","journal-title":"Veterinary journal"},{"key":"ref43","first-page":"45","article-title":"Phage display of recombinant antibodies toward Burkholderia pseudomallei exotoxin","volume":"6","author":"S Nathan","year":"2002","journal-title":"Journal of biochemistry, molecular biology, and biophysics: JBMBB: the official journal of the Federation of Asian and Oceanian Biochemists and Molecular Biologists"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<571::AID-IJC20>3.0.CO;2-1","article-title":"Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein","volume":"85","author":"J Bhatia","year":"2000","journal-title":"International journal of cancer Journal international du cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"15073","DOI":"10.1074\/jbc.M701654200","article-title":"Structural basis for recognition of CD20 by therapeutic antibody Rituximab","volume":"282","author":"J Du","year":"2007","journal-title":"The Journal of biological chemistry"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4049\/jimmunol.182.1.416","article-title":"Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes","volume":"182","author":"F Perosa","year":"2009","journal-title":"Journal of immunology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/978-1-61779-974-7_39","article-title":"Design and production of multimeric antibody fragments, focused on diabodies with enhanced clinical efficacy","volume":"907","author":"GA Powers","year":"2012","journal-title":"Methods in molecular biology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/138945009787354520","article-title":"Targeting: the ADEPT story so far","volume":"10","author":"KD Bagshawe","year":"2009","journal-title":"Current drug targets"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/bjc.1995.469","article-title":"Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs","volume":"72","author":"DC Blakey","year":"1995","journal-title":"British journal of cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jmb.2009.12.042","article-title":"Slowing bacterial translation speed enhances eukaryotic protein folding efficiency","volume":"396","author":"E Siller","year":"2010","journal-title":"J Mol Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2174\/1381612023393963","article-title":"Monoclonal antibody-based therapy strategies: providing options for the cancer patient","volume":"8","author":"DE Milenic","year":"2002","journal-title":"Current pharmaceutical design"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ncponc0774","article-title":"Technology insight: cytotoxic drug immunoconjugates for cancer therapy","volume":"4","author":"AD Ricart","year":"2007","journal-title":"Nature clinical practice Oncology"},{"issue":"Suppl 1","key":"ref53","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1007\/s00280-003-0595-y","article-title":"Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan","volume":"52","author":"K Tobinai","year":"2003","journal-title":"Cancer chemotherapy and pharmacology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1354\/vp.42-4-468","article-title":"CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma","volume":"42","author":"CM Jubala","year":"2005","journal-title":"Veterinary pathology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4161\/mabs.27240","article-title":"Drugs derived from phage display: from candidate identification to clinical practice","volume":"6","author":"AE Nixon","year":"2014","journal-title":"MAbs"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.febslet.2013.11.025","article-title":"Therapeutic antibody engineering by high efficiency cell screening","volume":"588","author":"A Doerner","year":"2014","journal-title":"FEBS Lett"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1038\/nprot.2007.455","article-title":"Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules","volume":"2","author":"SU Eisenhardt","year":"2007","journal-title":"Nat Protoc"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/bab.1080","article-title":"Comparison of two functional kappa light-chain transcripts amplified from a hybridoma","volume":"60","author":"J Yang","year":"2013","journal-title":"Biotechnol Appl Biochem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0148366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T16:33:07Z","timestamp":1600187587000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0148366"}},"subtitle":[],"editor":[{"given":"Edgar","family":"Meinl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,19]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0148366","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,19]]}}}